Stefania Scorzoni

发表

Gain-of-function genetic screens in human cells identify SLC transporters overcoming environmental nutrient restrictions

G. Superti-Furga, K. Klavins, V. Sedlyarov, 2022, Life Science Alliance.

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis

G. Superti-Furga, K. Bennett, A. Stukalov, 2015, Cell Death and Disease.

A time-resolved molecular map of the macrophage response to VSV infection

G. Superti-Furga, K. Bennett, B. Snijder, 2016, npj Systems Biology and Applications.

SLC38A9 is a component of the lysosomal amino acid-sensing machinery that controls mTORC1

G. Superti-Furga, K. Bennett, B. Snijder, 2014, Nature.

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis

G. Superti-Furga, K. Bennett, J. Colinge, 2015, Cell Death and Disease.

An Inducible Retroviral Expression System for Tandem Affinity Purification Mass-Spectrometry-Based Proteomics Identifies Mixed Lineage Kinase Domain-like Protein (MLKL) as an Heat Shock Protein 90 (HSP90) Client*

G. Superti-Furga, K. Bennett, J. Zuber, 2015, Molecular & Cellular Proteomics.

A substrate‐based ontology for human solute carriers

G. Superti-Furga, Eva Meixner, V. Sedlyarov, 2020, Molecular systems biology.

A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis

G. Superti-Furga, K. Bennett, A. Stukalov, 2015, Cell Death and Disease.

TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9

G. Superti-Furga, A. Müller, Patrick Essletzbichler, 2020, Nature.

Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking

G. Superti-Furga, A. Fauster, A. César-Razquin, 2018, Cell Death & Differentiation.